Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

A 3-month treatment improved PCOS symptoms and reduced certain immune proteins.

Cell death shapes skin stem cell environments, affecting inflammation, repair, and cancer.

Vitamin D is important for skin health and can help treat and prevent various skin conditions.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

New insights into cell communication in psoriasis suggest innovative drug treatments.

Histone modification is key in treating chronic inflammatory skin diseases.

The skin microbiome helps heal wounds and can be targeted to improve healing.

Exosomes from special stem cells help treat ulcerative colitis by reducing inflammation and stress.

Aged individuals heal wounds less effectively due to specific immune cell issues.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Certain gut bacteria may protect against alopecia areata, while others may increase the risk.

People with alopecia areata may have a higher risk of blood clots.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Targeting IL-17 could help treat pattern hair loss.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Early and proper treatment is crucial for children with allergic conjunctivitis to avoid complications.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Targeting NETs may help reduce fibrosis in Crohn's disease.